IL116615A - Transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole and of its salts - Google Patents
Transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole and of its saltsInfo
- Publication number
- IL116615A IL116615A IL11661595A IL11661595A IL116615A IL 116615 A IL116615 A IL 116615A IL 11661595 A IL11661595 A IL 11661595A IL 11661595 A IL11661595 A IL 11661595A IL 116615 A IL116615 A IL 116615A
- Authority
- IL
- Israel
- Prior art keywords
- methyl
- pyrrolidenyl
- isoxazole
- administration
- salts
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19501022A DE19501022C1 (de) | 1995-01-14 | 1995-01-14 | Transdermales therapeutisches System zur Verabreichung von (s)-3-Methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazol oder einem seiner pharmazeutisch akzeptablen Salze und Verfahren zu seiner Herstellung |
Publications (2)
Publication Number | Publication Date |
---|---|
IL116615A0 IL116615A0 (en) | 1996-03-31 |
IL116615A true IL116615A (en) | 1999-09-22 |
Family
ID=7751534
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11661595A IL116615A (en) | 1995-01-14 | 1995-12-29 | Transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole and of its salts |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0802790B1 (xx) |
JP (1) | JPH10511972A (xx) |
KR (1) | KR19980701419A (xx) |
AR (1) | AR001070A1 (xx) |
AT (1) | ATE292458T1 (xx) |
BR (1) | BR9607488A (xx) |
CA (1) | CA2210341A1 (xx) |
DE (2) | DE19501022C1 (xx) |
IL (1) | IL116615A (xx) |
NZ (1) | NZ298428A (xx) |
WO (1) | WO1996021434A1 (xx) |
ZA (1) | ZA96260B (xx) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9615628D0 (en) * | 1996-07-25 | 1996-09-04 | Smithkline Beecham Plc | Formulation |
DE10004790B4 (de) * | 2000-02-01 | 2004-09-09 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Verabreichung von Zaleplon, Verfahren zu seiner Herstellung und seine Verwendung |
DE10019067C1 (de) * | 2000-04-18 | 2001-10-04 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System zur Abgabe von Dofetilid und seine Verwendung |
DE10118282A1 (de) * | 2001-04-12 | 2002-12-05 | Lohmann Therapie Syst Lts | Haftkleber auf Basis von Ethylen-Vinylacetat-Copolymeren und Klebharzen, für medizinische Verwendungszwecke |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2153360T3 (es) * | 1991-05-29 | 2001-03-01 | Abbott Lab | Compuestos de isoxazol e de isotiazol que mejoran las funciones de razonamiento. |
DE4313928C2 (de) * | 1993-04-28 | 1996-09-19 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System zur kontrollierten Abgabe von Pilocarpin an die Haut, Verfahren zu seiner Herstellung und seine Verwendung |
DE4336557C2 (de) * | 1993-05-06 | 1997-07-17 | Lohmann Therapie Syst Lts | Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung |
US5494680A (en) * | 1993-12-08 | 1996-02-27 | Minnesota Mining And Manufacturing Company | Transdermal delivery device |
-
1995
- 1995-01-14 DE DE19501022A patent/DE19501022C1/de not_active Expired - Fee Related
- 1995-12-29 IL IL11661595A patent/IL116615A/xx not_active IP Right Cessation
-
1996
- 1996-01-10 WO PCT/EP1996/000074 patent/WO1996021434A1/de active IP Right Grant
- 1996-01-10 JP JP8521426A patent/JPH10511972A/ja not_active Ceased
- 1996-01-10 NZ NZ298428A patent/NZ298428A/en unknown
- 1996-01-10 CA CA002210341A patent/CA2210341A1/en not_active Abandoned
- 1996-01-10 DE DE59611212T patent/DE59611212D1/de not_active Expired - Fee Related
- 1996-01-10 KR KR1019970704809A patent/KR19980701419A/ko active IP Right Grant
- 1996-01-10 EP EP96900309A patent/EP0802790B1/de not_active Expired - Lifetime
- 1996-01-10 AT AT96900309T patent/ATE292458T1/de not_active IP Right Cessation
- 1996-01-10 BR BR9607488A patent/BR9607488A/pt not_active Application Discontinuation
- 1996-01-12 ZA ZA96260A patent/ZA96260B/xx unknown
- 1996-01-12 AR AR33502496A patent/AR001070A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
KR19980701419A (ko) | 1998-05-15 |
BR9607488A (pt) | 1997-12-23 |
MX9705324A (es) | 1997-10-31 |
IL116615A0 (en) | 1996-03-31 |
EP0802790A1 (de) | 1997-10-29 |
AR001070A1 (es) | 1997-09-24 |
EP0802790B1 (de) | 2005-04-06 |
JPH10511972A (ja) | 1998-11-17 |
DE59611212D1 (de) | 2005-05-12 |
CA2210341A1 (en) | 1996-07-18 |
NZ298428A (en) | 1999-10-28 |
ZA96260B (en) | 1996-08-01 |
ATE292458T1 (de) | 2005-04-15 |
DE19501022C1 (de) | 1996-06-05 |
WO1996021434A1 (de) | 1996-07-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0739626A3 (en) | Transdermal therapeutic system with controlled drug release | |
AU4449789A (en) | Delivery system for pharmaceutical or therapeutic actives | |
GB2303064B (en) | Medicament for nasal administration | |
EP0858334A4 (en) | IMMEDIATE AND SLOW RELEASE ANALGESIC PHARMACEUTICAL COMPOSITION | |
PL330814A1 (en) | Compounds for and methods of delivering pharmaceutical preparations and their application | |
GB9601969D0 (en) | A system for the delivery of drugs and therapeutic agents | |
AU5397996A (en) | Iontophoretic transdermal system for the administration of at least two substances | |
DE69326539D1 (de) | Zytotoxische arzneimittel therapie | |
HUP0104803A3 (en) | Process and system for the administration of medicine through the skin | |
AU2782592A (en) | Thermal enhancement of transdermal drug administration | |
AU1429697A (en) | Systems and methods for the transdermal administration of androgenic agents | |
ZA968905B (en) | Transdermal therapeutic system (tts) for administering active substances for drug dependence or drug addiction | |
ZA9670B (en) | Composition and methods for transdermal delivery of acid-lability drugs | |
HUP9801130A3 (en) | Transdermal therapeutic system for administering testosterone | |
ZA891718B (en) | Orally administered system for the controller release of active substances | |
GB9700737D0 (en) | Administration of drugs | |
IL116615A (en) | Transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole and of its salts | |
HK1015681A1 (en) | Rate-controlled transdermal administration of risperidone | |
ZA966842B (en) | Transdermal administration of vorozole. | |
AU4391196A (en) | A transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidinyl)-isoxazole or one of its pharmaceutically acceptable salts | |
SI0859595T1 (en) | Therapeutic preparation for the transdermal administration of active substances | |
IE900913L (en) | Transdermal system for controlled administration of active¹ingredients | |
GB9503322D0 (en) | Medicament administration dummy | |
IL126778A0 (en) | Administration of histamine for therapeutic purposes | |
AU5193796A (en) | Release controlled transdermal therapeutic system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |